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Abstract
Pain is an important defense mechanism that protects us from 
environmental factors that might harm us. Our body's response to pain 
helps us to avoid injury. However, constant pain is a problem. Management 
of constant pain is an important area of research. Studies have shown that 
genetic variation contributes to the pain sensitivity. Numerous pain-related 
genes and their functional polymorphisms (CYP450, MOR-1, COMT, 
GCH1, etc.) have been identified in the past ten years. In particular, three 
opioid receptors (OPRM, OPRD and OPRK) are associated with pain 
sensitivity. One of the most well studied human functional polymorphisms 
is the debrisoquine/sparteine polymorphism of CYP2D6 (encoding the 
P450 2D6 enzyme). CYP2D6 is an important metabolic gene associated 
with the metabolism of many of opioid receptors including codeine, 
hydrocodone, and tramadol. A complete lack of sensitivity to pain is a 
dangerous genetic mutation that can lead to the premature death of an 
individual. A total loss of pain has been seen in six distinct rare hereditary 
syndromes, called the ‘channelopathy-associated insensitivity to pain’. 
This poster summarizes recent research into pain sensitivity genes. A better 
understanding of genes that contribute to pain sensitivity could lead to 
better ways of managing constant pain. 
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• Numerous studies have provided evidence of association between 
pain sensitivity and genetic variability. 
• There are genetic variants that  associated with absent or decreased 
pain, as well as variants associated with increased effectiveness of 
analgesic therapy. 
• Mutations in the SCN9A gene coding for the α-subunit of the 
voltage-gated sodium channel is associated with dysfunction in 
three different human pain disorders.
• Channelopathy- associated insensitivity to pain (CIP) is of 
particular interest as it is characterized by a complete lack of 
sensitivity to pain. CIP is inherited via an autosomal recessive (AR) 
trait. 
• Mutations in CYP450 enzymes have been associated with 
differences in metabolism of various drugs, including a 
number of analgesic agents. 
• Patients can be classified as extensive metabolizers (EM) +/+, 
intermediate metabolizers (IM) +/-, poor metabolizers (PM)
• -/-, and ultra-rapid metabolizers (UM) -/-/-/- based on how 
effectively they metabolize a medication, which is based on 
how many copies of normal or abnormal alleles they inherited. 
• CYP2D6 is an important metabolic gene associated with the 
metabolism of many of opioids including codeine, 
hydrocodone, and tramadol.
Pharmacokinetics of an opioid after it has been taken orally is 
illustrated in Figure 2. The drug will be absorbed through the gut 
and distributed to other organs, including  central nervous 
system,  through the bloodstream. An opioid will be metabolized 
in liver and excreted through kidneys. Pharmacodynamic of an 
opioid shows its action site and its physiological effect on body. 
• Genetic variability is not the only factor affecting pain 
sensitivity. There are studies which suggest that sleep, 
psychological distress and blood pressure can affect pain 
perception. There is also documented association between 
pain (particularly visceral pain) and psychometric indices such 
as anxiety and neuroticism.
• Gender accounted for approximately 20% of the variance in 
thermal pain sensitivity. Hormonal differences, differences in 
skin thickness between males and females or neurobiological 
factors may play a role.
Figure 2. Analgesic pathway in human body
(Figure retrieved from Meng- Meng Bao, Fang Xie, Xue-Yang Li, Yun Yue, Yun 
Guan, Yun Wang ) 
Figure 3. Pain thresholds in men and women 
(Figure retrieved from  Sato et al.)
Figure 1. Clinical cases  in which voltage-gated sodium channel activity is altered
(Figure retrieved from Joost P.H. Drenth, Stephen G. Waxman)
There is an apparent difference in pain thresholds 
between men and women that can be seen in Figure 3.  
Men have higher pain thresholds in both thermal skin 
and mechanical muscle pain comparing to women. 
Lines show the median values. 
This review is a summary of related studies. These 
studies  can be used as an aid in recognizing individual 
variations in pain sensitivity, treatment response and 
susceptibility from acute to chronic pain in surgical and 
cancer patients. Further studies on this topic are needed 
in order to identify additional factors affecting pain 
sensitivity. It is also necessary to create more universal 
methods of classifying patients based on their 
postoperative pain and treatment response.
